NOVODIAX INC

Novodiax Inc. is a biotech startup based in Hayward, California. The company employs 7 people and generates over $10,000 in annual revenue. Novodiax specializes in developing innovative rapid immunoassays for cancer and autoimmunity diagnostics. Their flagship product, ihcDirect®, is an in vitro diagnostic (IVD) assay that provides immunohistochemistry (IHC) results in as little as 10 minutes on frozen tissues. This technology also offers workflow benefits for formalin-fixed, paraffin-embedded (FFPE) tissues, reducing assay time by up to 40-60 minutes. ihcDirect® works by directly conjugating primary antibodies to a proprietary and sensitive polymerized horseradish peroxidase (polyHRP) detection system. This allows for rapid, efficient, and sensitive immunoassays for histology and cytology. The assays are designed to be user-friendly, requiring minimal lab space and no specialized equipment, and can be performed at room temperature. For more information about Novodiax's products and services, visit their website at www.novodiax.com or contact them at [email protected].